Skip to main content

Genome-Based Therapeutics Targeted Drug Discovery and Development: Workshop Summary (2012) / Chapter Skim
Currently Skimming:

Appendix C: Statement of Task
Pages 81-82

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 81...
... The goal of the workshop will be to discuss how genomic and genetic data has been and will be used in the drug development process to improve aspects such as target identification, clinical trial design, pharmacogenomics approaches, biomarker development, and understanding disease biology. The workshop will also investigate the economic drivers, incentives, and models that use genomics in drug development.
Read the entire page →

Key Terms

  • planning committee
  • pharmacogenomics approaches
  • institutional policy
  • individually authored
  • clinical trial

  • designated rapporteur
  • improve aspects
  • genetic data
  • disease biology
  • understanding disease

  • authored summary
  • trial design
  • target identification
  • biomarker development
  • workshop agenda

  • economic drivers
  • development process
  • invite speakers


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.